Reports

Report | CALPIRG | Health Care

Top Twenty Pay-For-Delay Drugs

Californians with cancer, heart disease, epilepsy and other conditions have been forced to pay an average of 10 times more than necessary for at least 20 blockbuster drugs, according to a report released today by California Public Interest Research Group (CALPIRG) and Community Catalyst.

 

 

The report, “Top Twenty Pay-for-Delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers,” reveals that these drugs were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

Report | CALPIRG Education Fund

Comments on the Health Net Life Insurance Company Proposal to Submit New Plans, Effective 1 January, 2014.

Overall Health Net's proposed rates appear to be unreasonably high when compared to identical products offered by competing health insurance providers.

Report | CALPIRG Education Fund | Consumer Protection

The Future is Calling

CALPIRG Education Fund releases a new report titled explaining how mobile payment systems work while providing consumers with the information they need to best utilize mobile payment systems in a safe and secure way.

Report | CALPIRG | Higher Ed

Issue Brief: Student Loan Debt in California

Without a new plan from Congress, on July 1 the interest rate on subsidiezed Stafford student loans will double, from 3.4 percent to 6.8 percent. This brief highlights the impact on California borrowers and the California economy.

Report | CALPIRG Education Fund | Public Health, Consumer Protection

Comments on the Blue Shield of California Proposal to Increase Small Employer Health Insurance Rates, Effective July 1, 2013.

After analysis of the complete filing – inclusive of the three subsequent submissions – it appears that for the most part, Blue Shield provided sufficient background data for the requested rate increase. However, we note that it took repeated requests for Blue Shield to provide the information necessary to justify the rate increase.

Pages

Subscribe to More Reports

Priority Action

The overuse of antibiotics on factory farms is threatening the effectiveness of lifesaving antibiotics. Call on the state Legislature to ban the mass distribution of antibiotics to livestock.

Support Us

Your donation supports CALPIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.